354 related articles for article (PubMed ID: 29168270)
1. A comparative evaluation of a new fully automated assay for von Willebrand factor collagen binding activity to an established method.
Stufano F; Baronciani L; Mane-Padros D; Cozzi G; Faraudo S; Peyvandi F
Haemophilia; 2018 Jan; 24(1):156-161. PubMed ID: 29168270
[TBL] [Abstract][Full Text] [Related]
2. Comparison of an automated chemiluminescent assay to a manual ELISA assay for determination of von Willebrand Factor collagen binding activity on VWD plasma patients previously diagnosed through molecular analysis of VWF.
Jousselme E; Jourdy Y; Rugeri L; Négrier C; Nougier C
Int J Lab Hematol; 2018 Feb; 40(1):77-83. PubMed ID: 28980759
[TBL] [Abstract][Full Text] [Related]
3. A two-centre comparative evaluation of new automated assays for von Willebrand factor ristocetin cofactor activity and antigen.
Stufano F; Lawrie AS; La Marca S; Berbenni C; Baronciani L; Peyvandi F
Haemophilia; 2014 Jan; 20(1):147-53. PubMed ID: 24028703
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of a von Willebrand factor three test panel and chemiluminescent-based assay system for identification of, and therapy monitoring in, von Willebrand disease.
Favaloro EJ; Mohammed S
Thromb Res; 2016 May; 141():202-11. PubMed ID: 26743192
[TBL] [Abstract][Full Text] [Related]
5. Comparison of a new chemiluminescent immunoassay for von Willebrand factor activity with the ristocetin cofactor-induced platelet agglutination method.
Cabrera N; Moret A; Caunedo P; Cid AR; Vila V; España F; Aznar JA
Haemophilia; 2013 Nov; 19(6):920-5. PubMed ID: 23730809
[TBL] [Abstract][Full Text] [Related]
6. Comparison of von Willebrand factor (VWF) activity levels determined by HemosIL AcuStar assay and HemosIL LIA assay with ristocetin cofactor assay by aggregometry.
Sagheer S; Rodgers S; Yacoub O; Dauer R; Mcrae S; Duncan E
Haemophilia; 2016 May; 22(3):e200-7. PubMed ID: 27076201
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of a fully automated von Willebrand factor assay panel for the diagnosis of von Willebrand disease.
Stufano F; Baronciani L; Bucciarelli P; Boscarino M; Colpani P; Pagliari MT; Peyvandi F
Haemophilia; 2020 Mar; 26(2):298-305. PubMed ID: 32107842
[TBL] [Abstract][Full Text] [Related]
8. Validation of a new panel of automated chemiluminescence assays for von Willebrand factor antigen and activity in the screening for von Willebrand disease.
Verfaillie CJ; De Witte E; Devreese KM
Int J Lab Hematol; 2013 Oct; 35(5):555-65. PubMed ID: 23551532
[TBL] [Abstract][Full Text] [Related]
9. Comparative study on collagen-binding enzyme-linked immunosorbent assay and ristocetin cofactor activity assays for detection of functional activity of von Willebrand factor.
Turecek PL; Siekmann J; Schwarz HP
Semin Thromb Hemost; 2002 Apr; 28(2):149-60. PubMed ID: 11992238
[TBL] [Abstract][Full Text] [Related]
10. Laboratory Testing for von Willebrand Factor Collagen Binding (VWF:CB).
Favaloro EJ; Mohammed S
Methods Mol Biol; 2017; 1646():417-433. PubMed ID: 28804845
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of commercial von Willebrand factor collagen binding assays to assist the discrimination of types 1 and 2 von Willebrand disease.
Favaloro EJ
Thromb Haemost; 2010 Nov; 104(5):1009-21. PubMed ID: 20806123
[TBL] [Abstract][Full Text] [Related]
12. von Willebrand disease in a pediatric-based population--comparison of type 1 diagnostic criteria and use of the PFA-100 and a von Willebrand factor/collagen-binding assay.
Dean JA; Blanchette VS; Carcao MD; Stain AM; Sparling CR; Siekmann J; Turecek PL; Lillicrap D; Rand ML
Thromb Haemost; 2000 Sep; 84(3):401-9. PubMed ID: 11019962
[TBL] [Abstract][Full Text] [Related]
13. Desmopressin therapy to assist the functional identification and characterisation of von Willebrand disease: differential utility from combining two (VWF:CB and VWF:RCo) von Willebrand factor activity assays?
Favaloro EJ; Thom J; Patterson D; Just S; Dixon T; Koutts J; Baccala M; Rowell J; Baker R
Thromb Res; 2009 Apr; 123(6):862-8. PubMed ID: 19064279
[TBL] [Abstract][Full Text] [Related]
14. Performance and clinical utility of a commercial von Willebrand factor collagen binding assay for laboratory diagnosis of von Willebrand disease.
Popov J; Zhukov O; Ruden S; Zeschmann T; Sferruzza A; Sahud M
Clin Chem; 2006 Oct; 52(10):1965-7. PubMed ID: 16887898
[TBL] [Abstract][Full Text] [Related]
15. A comparative analysis of different automated von Willebrand factor glycoprotein Ib-binding activity assays in well typed von Willebrand disease patients.
Vangenechten I; Mayger K; Smejkal P; Zapletal O; Michiels JJ; Moore GW; Gadisseur A
J Thromb Haemost; 2018 Jul; 16(7):1268-1277. PubMed ID: 29742318
[TBL] [Abstract][Full Text] [Related]
16. Towards improved diagnosis of von Willebrand disease: comparative evaluations of several automated von Willebrand factor antigen and activity assays.
Favaloro EJ; Mohammed S
Thromb Res; 2014 Dec; 134(6):1292-300. PubMed ID: 25300811
[TBL] [Abstract][Full Text] [Related]
17. Gain-of-function GPIb ELISA assay for VWF activity in the Zimmerman Program for the Molecular and Clinical Biology of VWD.
Flood VH; Gill JC; Morateck PA; Christopherson PA; Friedman KD; Haberichter SL; Hoffmann RG; Montgomery RR
Blood; 2011 Feb; 117(6):e67-74. PubMed ID: 21148813
[TBL] [Abstract][Full Text] [Related]
18. Technological advances in diagnostic testing for von Willebrand disease: new approaches and challenges.
Hayward CP; Moffat KA; Graf L
Int J Lab Hematol; 2014 Jun; 36(3):334-40. PubMed ID: 24750680
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of an automated method for measuring von Willebrand factor activity in clinical samples without ristocetin.
Graf L; Moffat KA; Carlino SA; Chan AK; Iorio A; Giulivi A; Hayward CP
Int J Lab Hematol; 2014 Jun; 36(3):341-51. PubMed ID: 24750681
[TBL] [Abstract][Full Text] [Related]
20. Laboratory Testing for von Willebrand Factor Ristocetin Cofactor (VWF:RCo).
Mohammed S; Favaloro EJ
Methods Mol Biol; 2017; 1646():435-451. PubMed ID: 28804846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
